6 June 2023
ECO Animal Health Group plc
("ECO" or the "Company")
Issue of Equity and Total Voting Rights
ECO Animal Health Group plc, a leader in the development, registration and marketing of pharmaceutical products for global animal health markets, confirms that a former employee has exercised options over 22,973 ordinary shares of 5 pence each ("Ordinary Shares") under the Company's Deferred Bonus Scheme.
Application has been made to the London Stock Exchange for 22,973 new Ordinary Shares to be admitted to trading on AIM. Admission and dealings in the new Ordinary Shares is expected to occur at 8.00 a.m. on 9 June 2023.
The new Ordinary Shares will rank pari passu with the existing Ordinary Shares.
Total Voting Rights
Following Admission, the Company's total issued share capital will consist of 67,744,889 Ordinary Shares with one voting right per share. The Company does not hold any Ordinary Shares in treasury. The total number of voting rights in the Company is therefore 67,744,889.
The above figure of 67,744,889 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Enquiries
| ECO Animal Health Group plc | 0208 447 8899 |
| David Hallas (CEO) |
|
| Chris Wilks (CFO) |
|
|
|
|
| IFC Advisory | 0203 934 6630 |
| Graham Herring / Zach Cohen |
|
|
|
|
| Singer Capital Markets (Nominated Adviser & Joint Broker) | 0207 496 3051 |
| Phil Davies / George Tzimas / Sam Butcher |
|
|
|
|
| Investec (Joint Broker) | 0207 597 5970 |
| Gary Clarence / Daniel Adams / Carlo Spingardi |
|
|
|
|
| Equity Development | 0207 065 2692 |
| Hannah Crowe / Matt Evans |
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.